BIIB - Biogen Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$219.72
DETAILS
HIGH:
$260.00
LOW:
$157.00
MEDIAN:
$225.00
CONSENSUS:
$219.72
UPSIDE:
13.88%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 298,437 | $54.7M | 0.2% | +21,628 | INCREASED |
| Cooperman | 6,400 | $1.2M | 0.0% | -- | UNCHANGED |
| Wood | 4,700 | $861,651 | 0.0% | -996,800 | DECREASED |
| Dalio | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-09 | Mantas Jesus B | director | A-Award | 1,505 | -- | -- |
| 2026-06-09 | Pangalos Menelas N | director | M-Exempt | 2,370 | -- | -- |
| 2026-06-09 | Minor Lloyd | director | A-Award | 1,505 | -- | -- |
| 2026-06-09 | Rowinsky Eric K | director | A-Award | 1,505 | -- | -- |
| 2026-06-09 | Pangalos Menelas N | director | A-Award | 1,505 | -- | -- |
| 2026-06-09 | SHERWIN STEPHEN A | director | A-Award | 1,505 | -- | -- |
| 2026-06-09 | HAWKINS WILLIAM A | director | A-Award | 1,505 | -- | -- |
| 2026-06-09 | LANGER SUSAN | director | A-Award | 1,505 | -- | -- |
| 2026-06-09 | Patolawala Monish D | director | A-Award | 1,505 | -- | -- |
| 2026-06-09 | Freire Maria C | director | A-Award | 2,005 | -- | -- |
| 2026-05-01 | Keeney Adam | officer: Head of Corporate Development | F-InKind | 455 | $187.06 | $85K |
| 2026-05-01 | Keeney Adam | officer: Head of Corporate Development | M-Exempt | 939 | -- | -- |
| 2026-04-01 | Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 181 | -- | -- |
| 2026-04-01 | Godbout Sean | officer: Chief Accounting Officer | F-InKind | 54 | $183.78 | $10K |
| 2026-02-13 | ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | A-Award | 8,450 | -- | -- |
| 2026-02-13 | Keeney Adam | officer: Head of Corporate Development | A-Award | 8,025 | -- | -- |
| 2026-02-13 | Izzar Rachid | officer: Head of Global Product Strat. | A-Award | 7,390 | -- | -- |
| 2026-02-13 | Grogan Jane | officer: Head of Research | A-Award | 8,450 | -- | -- |
| 2026-02-13 | Singhal Priya | officer: Head of Development | A-Award | 10,560 | -- | -- |
| 2026-02-13 | Godbout Sean | officer: Chief Accounting Officer | A-Award | 1,800 | -- | -- |
| 2026-02-13 | Gregory Ginger | officer: EVP, Human Resources | A-Award | 8,025 | -- | -- |
| 2026-02-13 | Murphy Nicole | officer: Head of Pharm Ops and Tech | A-Award | 10,560 | -- | -- |
| 2026-02-13 | Viehbacher Christopher | director, officer: President and CEO | A-Award | 38,015 | -- | -- |
| 2026-02-12 | Murphy Nicole | officer: Head of Pharm Ops and Tech | BUY | 3 | $195.03 | $585 |
| 2026-02-13 | Kramer Robin | officer: Chief Financial Officer | A-Award | 8,450 | -- | -- |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-07-08 | Maria Elvira Salazar | HOUSE | Sale | $15,001 - $50,000 |
| 2026-07-03 | Gilbert Cisneros | HOUSE | Purchase | $1,001 - $15,000 |
| 2026-06-09 | Maria Elvira Salazar | HOUSE | Purchase | $50,001 - $100,000 |
| 2026-06-09 | Maria Elvira Salazar | HOUSE | Purchase | $1,001 - $15,000 |